Opendata, web and dolomites

SKIN SUBSTITUTE SIGNED

Development of hybrid artificial skin substitute for chronic diabetic wounds

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SKIN SUBSTITUTE project word cloud

Explore the words cloud of the SKIN SUBSTITUTE project. It provides you a very rough idea of what is the project "SKIN SUBSTITUTE" about.

group    polymer    secondment    acting    prof    people    histological    rabbit    strategies    leadership    ulcer    agents    hmsc    papy    synthetic    dulce    model    medical    hybrid    fda    antibacterial    worse    career    international    it    68    therapeutic    culture    patients    establishing    fibroblast    ago    pandit    controls    time    incidence    motivation    reg    functionalized    vivo    plan    biology    24    discipline    43    antimicrobial    cellular    million    clinic    translate    completion    collaborative    incorporating    diabetic    wound    integra    gold    regulatory    bioactive    combines    cell    setting    vitro    diversity    2030    approved    substitute    first    device    models    nanoparticles    malignancies    standards    maturity    strategy    evaluation    alloxan    clinical    biopolymer    network    scaffold    amputation    techniques    goals    commercial    14    benefit    skin    healing    innovative    requiring    exchequer    professional    position    progress    compatibility    interventions    efficacy    reimbursement    keratinocyte    validate    intellectual    alloderm    foot    zno    leveraging    me    property    transferable    diabetes    skills    dfu    molecular    trial    garcia    grafts    components    stereological    training    15    3d    communication    mortality    independence    affairs    complementary   

Project "SKIN SUBSTITUTE" data sheet

The following table provides information about the project.

Coordinator
NATIONAL UNIVERSITY OF IRELAND GALWAY 

Organization address
address: UNIVERSITY ROAD
city: Galway
postcode: H91
website: www.nuigalway.ie

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Total cost 187˙866 €
 EC max contribution 187˙866 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2020-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    NATIONAL UNIVERSITY OF IRELAND GALWAY IE (Galway) coordinator 187˙866.00

Map

 Project objective

It is estimated that the incidence of diabetes in Europe will affect 43 million people by 2030. 15% of diabetic patients develop a diabetic foot ulcer (DFU) with 14-24% of these patients requiring amputation. Mortality following amputation of 50–68% is comparable or worse than for most malignancies. My strategy will develop for the first time a skin substitute which combines a biopolymer and a functionalized synthetic FDA approved polymer incorporating bioactive components and AgO and ZnO nanoparticles as antibacterial agents. The cellular compatibility of the hybrid skin substitute will be assessed on fibroblast, keratinocyte and hMSC in a 3D cell culture model. The antimicrobial efficacy will be assessed in vitro and in vivo. The optimised scaffold will be assessed in an alloxan-induced diabetic rabbit ulcer model with gold standards Integra® and Alloderm® skin grafts acting as commercial controls to validate the commercial potential of the technology. Progress to completion will be reviewed by a Research and Professional Development Plan which will provide both discipline-specific and complementary technical training (molecular biology, diabetic wound healing in vivo models, and histological and stereological techniques) and generic and complementary transferable skills training (e.g. intellectual property, leadership skills, motivation skills, communication skills, leveraging non-exchequer funding, regulatory affairs, clinical trial design, reimbursement strategies, medical device evaluation and regulatory affairs). I will benefit from Prof Pandit’s and Prof Dulce Papy-Garcia (secondment) international collaborative network in the field of diabetic wound healing. This training will facilitate me to achieve my future career goals of achieving a position of professional maturity, diversity and independence by establishing my own research group at a leading European institution and enabling me to translate innovative therapeutic interventions to the clinic setting.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SKIN SUBSTITUTE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SKIN SUBSTITUTE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

COSMOS (2020)

The Conformation Of S-phase chroMOSomes

Read More  

COR1-TCELL (2019)

Analysis of the role for coronin 1-dependent cell density signalling in T-cell homeostasis

Read More  

GENESIS (2020)

unveilinG cEll-cell fusioN mEdiated by fuSexins In chordateS

Read More